Published in Int J Radiat Oncol Biol Phys on April 15, 2013
Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon. Radiat Oncol J (2014) 0.85
Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. Radiat Oncol (2014) 0.80
Image-guided hypofractionated radiotherapy in low-risk prostate cancer patients. Biomed Res Int (2014) 0.77
Target margins in radiotherapy of prostate cancer. Br J Radiol (2016) 0.75
Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer. Rep Pract Oncol Radiother (2016) 0.75
Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med (2011) 7.46
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol (2006) 4.88
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol (2012) 3.96
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol (2003) 2.69
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst (2006) 2.61
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol (2014) 2.42
Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box? Int J Radiat Oncol Biol Phys (2010) 2.28
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys (2013) 2.02
An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys (2007) 2.00
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys (2005) 1.59
Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinations. Urology (2004) 1.47
Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol (2005) 1.31
A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. Int J Radiat Oncol Biol Phys (2010) 1.26
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys (2004) 1.24
Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys (2013) 1.19
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol (2008) 1.17
A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys (2006) 1.13
Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol (2012) 1.12
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. J Neurooncol (2011) 1.09
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Int J Radiat Oncol Biol Phys (2008) 1.08
Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer. Urology (2002) 1.07
A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys (2012) 1.06
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys (2005) 1.05
Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys (2004) 1.03
Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. Mol Cancer Ther (2004) 1.02
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis. Radiother Oncol (2013) 1.01
Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance. Cancer (2008) 1.01
Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study. Dis Colon Rectum (2002) 1.00
Pre-treatment risk stratification of prostate cancer patients: A critical review. Can Urol Assoc J (2012) 0.99
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). Int J Radiat Oncol Biol Phys (2007) 0.98
Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings. Int J Radiat Oncol Biol Phys (2007) 0.98
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. J Neurooncol (2011) 0.98
Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol (2009) 0.97
Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys (2007) 0.92
Killing two birds with one stone: a dosimetric study of dual target radiosurgery using a single isocenter. Technol Cancer Res Treat (2006) 0.92
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Int J Radiat Oncol Biol Phys (2009) 0.91
Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions. Gynecol Oncol (2005) 0.91
No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy. Urology (2006) 0.89
Evaluation criteria for film based intensity modulated radiation therapy quality assurance. Phys Med (2009) 0.88
Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol (2006) 0.88
Ultrasound-based image guided radiotherapy for prostate cancer: comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy. Int J Radiat Oncol Biol Phys (2006) 0.88
Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys (2005) 0.87
Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases. J Neurooncol (2009) 0.87
Inducible nitric oxide synthase and nitrotyrosine in mice with radiation-induced lung damage. Am J Clin Oncol (2003) 0.87
Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone. Radiother Oncol (2011) 0.86
The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys (2005) 0.86
Local correlation between monte-carlo dose and radiation-induced fibrosis in lung cancer patients. Int J Radiat Oncol Biol Phys (2008) 0.86
Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment. PLoS One (2013) 0.86
Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response. Int J Radiat Oncol Biol Phys (2011) 0.86
Hypofractionated radiotherapy for favorable risk prostate cancer. Int J Radiat Oncol Biol Phys (2010) 0.85
Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers. J Neurooncol (2010) 0.85
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer. J Clin Oncol (2005) 0.85
Development and impact evaluation of an e-learning radiation oncology module. Int J Radiat Oncol Biol Phys (2011) 0.85
Ductal carcinoma in situ--the influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys (2011) 0.84
Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy. Brachytherapy (2010) 0.84
Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Head Neck (2007) 0.84
Adaptation of wives to prostate cancer following diagnosis and 3 months after treatment: a test of family adaptation theory. Int J Nurs Stud (2006) 0.83
Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.83
Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am J Obstet Gynecol (2007) 0.83
Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis. Int J Radiat Oncol Biol Phys (2005) 0.83
Intra-operative echographic localization for radioactive ophthalmic plaques in choroidal melanoma. Ann N Y Acad Sci (2008) 0.83
Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer. Int J Radiat Oncol Biol Phys (2007) 0.82
Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article. J Neurosurg (2009) 0.82
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results. Int J Radiat Oncol Biol Phys (2011) 0.81
Tumor bed radiosurgery following resection of brain metastases: a review. Technol Cancer Res Treat (2010) 0.81
Volumetric measurement of vestibular schwannoma tumour growth following partial resection: predictors for recurrence. J Neurol Surg B Skull Base (2012) 0.81